Home BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
 

Keywords :   


BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research

2014-04-30 07:01:39| drugdiscoveryonline News Articles

BPS Bioscience, Inc. (BPS) is excited to announce a unique portfolio of 13 different mutant EZH2 complexes, including several markers for Weaver Syndrome

Tags: research cancer proteins syndrome

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »